Mark Cant

Mark Cant has a diverse work experience in the field of biotechnology and cell engineering. Mark started their career as a Product Development Technician at TC BioPharm Limited in April 2019 and worked there until August 2020. Mark then joined the University of Glasgow as a Laboratory Scientist from September 2020 to December 2020. Currently, Mark is employed at Resolution Therapeutics, where they initially worked as a Research Associate from January 2021 to June 2022. Mark has since been promoted to the role of Research Scientist - Cell Engineering, starting in June 2022.

Mark Cant obtained a Master's degree in Immunology from the University of Glasgow from 2017 to 2018. Prior to that, they completed their Bachelor of Science (BS) degree in Immunology from the University of Dundee, a four-year program that lasted from 2012 to 2016.